Search results “Use of tamoxifen for cardiovascular prevention”
Stop Breast Radiotherapy! Prefer Tamoxifen
Stop Breast Radiotherapy! Prefer Tamoxifen Radiotherapy is the most dangerous treatment of cancer. Nevertheless millions of breast cancer patients are exposed to it. Which is unnecessary. In order to prevent cancer recurrence, newly diagnosed women are irradiated. This procedure was recommended by the Early Breast Cancer Trialists' Collaborative Group (EBCTCG ) . Radiotherapy reduces cancer recurrence but has no effect on survival. Patients who underwent BCT have a higher breast cancer--specific survival rate compared with those treated with mastectomy alone or mastectomy with radiation for early-stage invasive ductal carcinoma" (Agarwal S. et al.) 2236 women were recruited into START-A 2215 women were recruited into START-B 67•2% deaths in START-B were from breast cancer 4•8% were related to cardiac disease only 13•7% were from other cancers 11•4% were from other non cancer causes, 2•8% were from unknown cause 64•7% of the deaths from cardiac disease were in women with left-sided primary tumours" Radiation destroys cells causing mammary gland cytopenia which later on is replaced by fibrocytes, and the breast becomes hardened. Breast shrinkage, and induration are indicators of similar changes in tissues under the isodose distribution. Breast is a biomarker of radiation damage in adjacent tissues. 48.6% of women had radiation damaged, lung, rib, sternum and heart. Damage intensity depends on their position under the isodose surface. It may be small but accumulates with time, and is irreversible. You have here two treatments for reduction of cancer recurrence. 1. Radiotherapy, with irreversible toxicities and no improvement of survival. 2. Tamoxifen, generally with reversible toxicities and improved survival. Tamoxifen does not damage with radiation isodoses, and is therefore much less risky Replace breast radiotherapy with tamoxifen. By the way I would not recommend any treatment for reducing tumor recurrence. Let it pop up and then put it to sleep.
Views: 1817 Gershom Zajicek M.D,
Tamoxifen Side Effects
http://www.sideeffectsuk.co.uk/ Tamoxifen Side Effects - Tamoxifen is used to fight breast cancer in women and also infertility in some cases. The side effects of this drug however, are quite extensive. It will affect your bones, central nervous system, cardiovascular and metabolic systems. Photos from freedigitalphotos.net
Views: 3695 medicinesideeffectz
Dr Pam Popper: Breast Cancer Prevention Start in Childhood; Risks/Benefits of Tamoxifen
Diet, exercise, weight are risk factors for developing breast cancer, and the best time to start addressing these issues is age 2, according to an expert. Tamoxifen is reported to reduce the risk of developing breast cancer by 29%. The real risk reduction is less than 3% and the risks are significant. Consider this information before agreeing to take this drug!
Views: 1757 Pamela Popper
Tamoxifen and Mammograms after breast cancer
Read and Watch the full story at http://www.nalie.ca Breast cancer treatments are done and I am considered Cancer Free... But that doesn't mean its "the end" of it. Post-treatments, women with hormonal cancers usually have to take Tamoxifen and get annual Mammograms! Read and Watch more details at http://www.nalie.ca
Views: 18819 Nalie Agustin
Treatment uses Tamoxifen to battle cancer
A Baltimore doctor says Tamoxifen is an option for patients to help prevent breast cancer reoccurrence. Subscribe to WBAL on YouTube now for more: http://bit.ly/1oJSRCN Get more Baltimore news: http://wbaltv.com Like us: http://facebook.com/wbaltv11 Follow us: https://twitter.com/wbaltv11 Google+: https://plus.google.com/+wbaltv11
Flaxseeds & Breast Cancer Survival: Clinical Evidence
Subscribe to Dr. Greger’s free nutrition newsletter at https://www.nutritionfacts.org/subscribe and get a free recipe from his new HOW NOT TO DIE COOKBOOK. (All proceeds Dr. Greger receives from the sales of his books, DVDs, and speaking engagements go to support the 501c3 nonprofit that runs NutritionFacts.org.) DESCRIPTION: A randomized double-blind placebo-controlled clinical trial of flaxseeds in breast cancer patients finds flax appears to have the potential to reduce tumor growth in just a matter of weeks. The population data I mention at the beginning is from the previous video Flaxseeds & Breast Cancer Survival: Epidemiological Evidence (http://nutritionfacts.org/video/flaxseeds-breast-cancer-survival-epidemiological-evidence/). And before that, the role lignan phytonutrients may play in prevention: Flaxseeds & Breast Cancer Prevention (http://nutritionfacts.org/video/flaxseeds-breast-cancer-prevention/). I have some more videos coming up on the role diet plays in angiogenesis, the formation of new blood vessels to enable tumors to grow, but I have touched on it already in Cancer as an Autoimmune Disease and How Tumors Use Meat to Grow: Xeno-Autoantibodies. The results here are similar to what was found with the other class of phytoestrogens found in soy (Breast Cancer Survival and Soy). A study similar to this was carried out in prostate cancer patients: Flaxseed vs. Prostate Cancer (http://nutritionfacts.org/video/flaxseed-vs-prostate-cancer/). This is the final video of a series on flax. Also feel free to check out the ones on diabetes (http://nutritionfacts.org/video/flaxseed-vs-diabetes/) and sensitive skin (http://nutritionfacts.org/video/flaxseeds-for-sensitive-skin/). Have a question for Dr. Greger about this video? Leave it in the comment section at http://nutritionfacts.org/video/flaxseeds-breast-cancer-survival-clinical-evidence/ and he'll try to answer it! http://www.NutritionFacts.org • Subscribe: http://www.NutritionFacts.org/subscribe • Donate: http://www.NutritionFacts.org/donate • HOW NOT TO DIE: http://nutritionfacts.org/book • Facebook: http://www.facebook.com/NutritionFacts.org • Twitter: http://www.twitter.com/nutrition_facts • Instagram: http://instagram.com/nutrition_facts_org/ • Google+: https://plus.google.com/+NutritionfactsOrgMD • Podcast: http://nutritionfacts.org/audio/
Views: 35112 NutritionFacts.org
Medicine Before Breast Cancer Strikes
http://www.dailyrx.com/breast-cancer-risk-reduced-women-taking-tamoxifen-and-evista http://www.dailyrx.com/conditions/breast-cancer-female Breast cancer risk may be reduced in at risk women taking certain medications. I'm Erin White and this is a dailyRx Minute. Women at risk for developing breast cancer may reduce their chances of developing the disease by nearly three-fold by taking medications such as Tamoxifen and Evista. The US Preventative Services Task Force is recommending at risk women between the ages of 40 and 70 discuss these medications with their doctors. Ask your doctor if preventative medication is right for you. For dailyRx TV, I'm Erin White.
Views: 200 dailyRx
New breast cancer drug study results are promising.
Researchers are encouraged by the early results for patients using Z-endoxifen. The potent derivative of the drug tamoxifen was given to women with estrogen receptor positive metastatic breast cancer, the most common form of breast cancer in women whose disease has spread. The phase I study demonstrated endoxifen shows promise for patients whose cancer had continued to progress with standard estrogen therapies, including tamoxifen.
Views: 1206 Mayo Clinic
Breast Cancer Treatment Side Effects Last for Years
More than 60% of breast cancer survivors report at least one treatment related complication even 6 years after their treatment. Thirty percent are dealing with two issues such as lymphedema, skin reactions to radiation, upper pody symptoms and functional limitations, weight gain, fatigue, and peripheral neuropathy from chemotherapy. Fragmented care leads to confusion and ignoring these complications. There are many treatments that can help these symptoms such as physical therapy, exercise, support groups, emotional support, infrared light therapy, and a healthly lifestyle that may proactively prevent a recurrence. Take Dr. Saputo's Breast Cancer Health Assessment Once you have breast cancer you need to know the best strategies to slow down or reverse its growth. In Dr. Saputo's Breast Cancer Health Assessment we will ask you about the type of breast cancer you have, what treatment you've considered or completed, whether or not you're interested in CAM approaches to treatment, and important lifestyle factors that could have an impact on how your cancer will affect you. You will immediately be emailed back audios and videos Dr. Saputo believes will guide you to information that can help you manage your cancer and support the body's immune defenses. There is a lot we can do to prevent activating cancer genes and to protect us from developing breast cancer. Most breast cancers are epigenetic, not genetic! http://doctorsaputo.com/a/breast-cancer-health-assessment
Views: 1649 DoctorSaputo
Dr. Richard Gray Describes a Longer Duration of Treatment With Tamoxifen
Richard G. Gray, MA, MSc, a professor of medical statistics at the University of Oxford in Oxford, United Kingdom, discusses the phase III aTTom trial that explored a longer duration of treatment with tamoxifen in women with estrogen receptor-positive early breast cancer. This trial was presented at the 2013 ASCO Annual Meeting. For more from this meeting, visit http://www.onclive.com/conference-coverage/asco-2013
Views: 317 OncLiveTV
Breast Cancer: Surgery But No Chemo or Tamoxifen
They were pushing HRT to everyone who came to the clinic. I was on hormone therapy for 2 years. Then I got breast cancer. I had mastectomy with removal of lymph nodes. The doctor said, "You must do chemo." I refused and asked for other options. Then I got your contact. I was asked to take tamoxifen, but I refused. I go for routine check up every 3 months for 4 years. Fifth year on, it was every 6-monthly. Everything is alright. Today April 2009, patient is doing very well and happy.
Views: 2889 Chris Teo
Cardiovascular Disease and Long-Term Breast Cancer Survivorship
Dr. Jennifer Klemp is familiar with the correlation of breast cancer and cardiovascular disease. In this video, she advises survivors to make some lifestyle changes to help avoid developing cardiovascular problems. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/user/drjayharness VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS http://www.breastcanceranswers.com/ SUBMIT A QUESTION http://www.breastcanceranswers.com/ DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/ CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers Twitter: https://twitter.com/BreastCancerDr
Irradiation of the left breast damages the heart. Avoid it!
Irradiation of the left breast damages the heart and should be avoided In a presentation: Breast irradiation is dangerous and should be avoided, I showed that this treatment causes radiation pneumonitis. Nevertheless any woman with breast cancer will receive radiation therapy. Medicine claims that radiation is essential for cure. This conclusion is based on a false interpretation of recent meta-analyses by Early Breast Cancer Trialists' Collaborative Group (EBCTCG) . Recently it became clear that irradiation of the left breast irreversibly damages the heart. Nevertheless any woman with a tumor in her left breast will be irradiated. Again medicine claims that radiation is essential for cure which is based on the same false interpretation of meta-analyses by Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Irradiation does not eliminate the tumor and does not prolong survival. It only initiates tumor dormancy which may be achieved by less toxic treatments which do not damage the heart, like tamoxifen. Each quantum of x-rays irreversibly damages the heart and the effect is cumulative. Radiation to the thorax can damage the pericardium, myocardium, valves, and coronary vessels, with the pericardium being the most commonly involved . Radiotherapy of breast cancer does not cure. Neither does it improve survival and should therefore be prohibited.
Jenn Sutkowski -- Tamoxifen! (Reading My Weekly Column)
Hey hey! Thanks for stopping by! I'm here reading my weekly column -- this one is about the ups and downs of being on Tamoxifen, for prevention of breast cancer! As a breast cancer survivor I've chosen to have a sense of humor about some of the nutty stuff you deal with on this journey. Like the potential side effects of this miracle pill. I'm happy to report a year after making this video I'm still feeling great and my hangups about the medication have calmed. Or maybe I've just become a tamoxifen pod-person?! If you see a big white pill walking down the street, say hi! Or don't. ;-) Oh and the bits of music are by me. You can find me (and my free gift/tutorial on how to be funny with heart) at www.jennsutkowski.com. I’m on IG at www.instagram.com/jennsutkowski My FB public profile lives at www.facebook.com/jenniferbernicesutkowski And tweet me in the 140-character circle of hell that is Twitter at www.twitter.com/jennsutkowski Remember when #’s were for touchtone phones? Er, yeah, me neiths. ;-)
Views: 25 Jenn Sutkowski
Telma 40mg Tablet : Uses, Price, Side Effects, Composition in hindi
Telma 40mg Tablet : Uses, Price, Side Effects, Composition Telma 40mg Tableticon Glenmark Pharmaceuticals Ltd Composition for Telma 40mg Tablet Telmisartan (40mg) iconPrescription Required Primary uses of Telma Tablet High blood pressure Potentiallyunsafewith iconAlcohol MRP₹100.46 ₹6.7/Tablet 15 tablets in 1 strip 1 Strip ADD TO CART Available in other variants Medicine Overview In Depth Information Patient Concerns Medicine Overview of Telma Tablet uses Uses of Telma Tablet Telma 40mg Tablet is used in the treatment of high blood pressure Decreasing high blood pressure lowers the risk of heart attack and stroke. uses Telma Tablet side effects Common Dizziness, Back pain, Diarrhoea, Sinus inflammation, Increased potassium level in blood. uses How to use Telma Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Telma 40mg Tablet may be taken with or without food, but it is better to take it at a fixed time. How Telma Tablet works Telma 40mg Tablet is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. #MedicineReview,#hindi,#online
Views: 30437 Online Medicine Review
Dr Pam Popper: Early Warning Signs of Heart Disease; Is It Possible to Exercise Too Much?
Even a little bit of plaque significantly increases the risk of heart attack and death – here’s some motivation for improving your diet now! And, in case you are wondering, there is no such thing as exercising too much; the risk is in staying sedentary.
Views: 8706 Pamela Popper
Breast Cancer: Risks, Prevention, Diagnosis and Treatments
Robert Carlson, professor of oncology at the Stanford University School of Medicine, discusses which factors place a woman most at risk for breast cancer, the second leading cause of cancer-related death in women. And if cancer is discovered, what steps can be taken?
Views: 1933 ResearchChannel
Turmeric — More Effective Than These 7 Prescription Drugs
Turmeric — More Effective Than These 7 Prescription Drugs Please SUBSCRIBE : http://bit.ly/2e9Su11 Prescription drugs are the first aid you reach for when dealing with headaches, back and joint pain. Although some of the drugs can do the trick and help you, most of them come packed with a terrifying list of side-effects like stroke, heart attack, nausea, constipation, gastrointestinal problems, and others the like. You may be well aware of the potential of turmeric, but do you know that science has proven it to be more powerful than numerous drugs when it comes to relieving pain? Here is a brief list, and we can only imagine your surprise: 1. Lipitor / Astorvastatin (Cholesterol medication). According to a survey from the R&D Journal for Drugs, turmeric is more effective than Lipitor when it comes to endothelial dysfunction, which is an underlying pathology of blood vessels that relieves inflammations and oxidative stress in individuals who deal with type 2 diabetes. 2. Corticosteroids (Steroid drugs). Phytotherapy Research Journal published a study according to which curcumin, the active ingredient in turmeric, works better than steroids in cases of inflammatory eye disease. As you already know, corticosteroids come packed with some unpleasant side effects. 3. Prozac / Fluoxetine & Imipramine (Antidepressant). A study from the Acta Pharmaceutica Polonie Journal showed that turmeric reduces depressive behavior in a much better way than these health-harming drugs. 4. Aspirin (Blood thinner). Science has proven that turmeric can aid in the treatment of patients with vascular thrombosis and individuals who need anti-arthritis therapy. 5. Oxaliplatin (Chemo drug). According to the International Cancer Journal, turmeric is as effective as oxaliplatin, and it can act as an anti-proliferative agent. 6. Anti-inflammatory drugs. Another study that was published in the Oncogene journal showed that turmeric is a more powerful anti-inflammatory than aspirin, ibuprofen, sulindac, phenylbutazone, Naproxen, Indomethacin, diclofenac, dexmethasone, celecoxib, and Tamoxifen. 7. Metformin (Diabetes drug). A study from the Biochemistry and Biophysical Journal confirmed that turmeric can help diabetics. The yellowish spice activates AMPK and stimulates the uptake of glucose. It also suppresses glucose formation in hematoma cells. This research revealed that turmeric is 500-1,000 times more powerful than metformin when it comes to activating AMPK. The FDA introduced some changes in their warnings about the potential risks of many drugs, and the possibility of heart attacks and strokes. Manufacturers of non-steroidal anti-inflammatory drugs (NSAIDs) are now required to provide more accurate information regarding any potential risks on their labels. Pain will just take you to the nearest bottle of painkillers, but be aware of the risk you are exposing yourself to. Turmeric has been used as natural painkiller for so long, and now it has confirmed its effectiveness and safety. Polyphenols in turmeric provide an endless list of health benefits. Turmeric is natural, safe, powerful, cheap and available. Could you ask for more? Curcumin gives turmeric its anti-inflammatory potential. It is also a mighty antioxidant that relieves inflammation, which is why turmeric is used in the treatment of arthritis, heartburn, stomach ache, diarrhea, liver malfunction, gallbladder problems and many more. ================================== curcumin, turmeric, turmeric benefits, curcumin benefits, health benefits of turmeric, curcumin supplement, turmeric extract, turmeric uses, turmeric anti inflammatory, turmeric supplement benefits, natural cures, home remedies,Prescription Drugs, Scientifically Confirmed Turmeric Is More Effective, Turmeric Is More Effective, Turmeric Is More Effective Than These 14 Prescription Drugs, Benefits of Turmeric, surprising benefits of turmeric, turmeric for health, turmeric health tips, turmeric tips, proven health benefits of turmeric, Please SUBSCRIBE : http://bit.ly/2e9Su11
Views: 354 Health News
Docs: Drug used for cancer recurrence, prevention
Many women have heard about taking the drug Tamoxifen after they've had breast cancer to prevent a recurrence, but it's also used in chemoprevention, which is using a medication to prevent breast cancer.
Ask the Doc-Gyno problem during TRT.
Dr Rand talks about the best way to eliminate Estrogen build up causing gyro while on TRT.
Views: 4452 JayCutlerTV
STAR study on breast cancer prevention
Norma Kreutz of Pittsburgh tells about her participation in the STAR study, comparing raloxifene and tamoxifen as preventative agents for women at high risk of breast cancer. Dr. Thomas Julian of Allegheny General Hospital comments on what the study means for high-risk women.
UF study strengthens concerns about long-term use of certain painkillers
Painkillers such as ibuprofen, naxopren and celecoxib provide needed relief for many patients who have chronic pain. But an ongoing source of contention is whether those drugs and others in their class known as nonsteroidal anti-inflammatory drugs, or NSAIDs, are linked to harmful health effects. Now a new study from the University of Florida raises the concern about potential risks to a higher degree than before, finding a doubling of deaths from heart attack, stroke and related events among people who have both hypertension and coronary artery disease and use the drugs long term. The findings, based on data from the international INVEST clinical study of hypertension therapies, are published in the current issue of The American Journal of Medicine. "It does strengthen our practice recommendations," said lead author Anthony A. Bavry, M.D., M.P.H., an assistant professor of cardiovascular medicine in the UF College of Medicine's department of medicine. Physicians already discourage the use of NSAIDs among the elderly and after heart attacks, on the basis of several studies showing that the drugs are linked with a higher risk of stroke and heart attack. But the UF researchers, including senior author Carl J. Pepine, M.D., a professor of cardiovascular medicine in the UF College of Medicine, advise patients to talk to their doctors before stopping use of prescribed treatments. "It's a tricky issue, because NSAIDs are useful for relieving pain, and that is much of what we do in medicine — alleviate pain and suffering," said Deepak L. Bhatt, M.D., M.P.H., an associate professor of medicine at Harvard Medical School and chief of cardiology at the VA Boston Healthcare System, who recently published findings that NSAIDs are linked to a higher risk of stroke. "Unfortunately, most medications have some potential side effects, and it's important to know what those might be." Bhatt was not involved in the UF study. Patients who have both high blood pressure and coronary artery disease are generally put on aspirin, a unique type of NSAID, to reduce their risk of a heart attack. Physicians are concerned that giving those patients other NSAIDs for pain relief could cancel out aspirin's beneficial effects and raise the risk of negative cardiovascular effects. The UF research team took advantage of the availability of INVEST study data from 882 chronic NSAID users and almost 22,000 intermittent or nonusers to try to settle the question. They looked at patients who reported using NSAIDs over an average of about three years, to see whether there was an increase in adverse events or cardiovascular-related death compared with patients who did not use those pain medicines long term. The risk of death from cardiovascular causes was 2.3 times higher among patients who chronically used the drugs than among other patients. NSAIDs are thought to act in a variety of ways to increase cardiovascular risk. They are thought to prevent aspirin's protective anti-clotting effect by preventing the aspirin from binding properly to platelets in the blood. Some NSAIDs might also increase bleeding risk. In addition, NSAIDs raise blood pressure, thus potentially raising the risk of heart attack and stroke. Some NSAIDs have already been removed from the market because of concerns about an elevated risk of heart attack and stroke.
Views: 8701 UFHealth
Archana Ajmera on Stomatitis Prevention During Everolimus/Exemestane Treatment
Archana Ajmera, RN, MSN, WHNP-BC, ANP-BC, nurse practitioner, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses stomatitis prevention during everolimus/exemestane treatment for metastatic breast cancer
Views: 592 OncLiveTV
Genetic Test May Help Women at High Risk for Breast Cancer
A research study led by physicians at Allegheny General Hospital found that a certain genetic variation will predict whether women at high risk for breast cancer will respond to the preventive drugs tamoxifen and raloxifene. The findings from the study of more than 600 high-risk women are a step forward toward a time when all cancer care is tailored to a patient's individual genetics, said Dr. Thomas Julian, Director of Breast Surgical Oncology at Allegheny General, in an interview with KDKA-TV. To learn more about the treatment of breast cancer, visit http://www.wpahs.org/specialties/cancer-institute/breast-cancer
New treatment for aggressive breast cancer
Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumours through manipulation of the connective tissue cells of the tumour. The researchers are now developing a new drug that transforms aggressive breast cancer so that it becomes responsive to standard hormone therapy.
Views: 1686 LundUniversity
Fertility Concerns for Breast Cancer Rx
http://www.dailyrxnews.com/ A new study from the University of Michigan School of Medicine found that young women may be turning down an important breast cancer treatment because of fertility concerns. "Despite the importance of fertility to young breast cancer patients, availability of fertility preservation options, and relative safety of pregnancy among breast cancer survivors, fertility preservation is often underutilized and under-discussed in clinical settings," wrote lead study author Jacqueline S. Jeruss, MD, PhD, a professor of obstetrics and gynecology-fertility preservation at Northwestern University Feinberg School of Medicine, and colleagues. Tamoxifen (brand names Soltamox, Nolvadex) is used to decrease the risk of recurrence and death from breast cancer. Breast cancer patients should not become pregnant while on tamoxifen, as the drug may cause birth defects. The length of treatment may also narrow the window for a woman to conceive.
Views: 143 dailyRx
Hormone Therapy and Long Term Mortality
Read more at www.biobalancehealth.com JAMA, the Journal of the American Medical Association is one of the major pieces of literature that doctors read to obtain new information about the knowledge and practice of medicine. For years JAMA has been publishing articles challenging the use of Hormone Replacement Treatment, particularly for women. In the 1980s HRT took off as a miracle treatment for women who were aging and post -menopausal. Many doctors and their female patients were getting into this treatment it was an exciting time for women who wanted to live long and healthy lives. Then, in order to validate this movement in modern medicine, the Women’s Health Initiative put together a research program to check out the legitimacy of hormone replacement treatment. This research program was checking the replacement of estrogen and provera. In just a little time they obtained data that caused them to believe that women receiving this treatment were at an increased risk for breast cancer and death. The news media got on board and rushed to publish warnings to women and their doctors to say stop killing women! They did not really verify the research they just accepted the warning and rushed out to say the sky is falling. Dr. Maupin had been watching this issue unfold. After twenty five years as a gynecologist treating women who became postmenopausal she did not see an increase in breast cancer or death in women who received HRT. So she continued to practice medicine the way she knew and used the data and the research she had obtained from Europe to bolster her argument that the treatment was safe and efficacious. Many doctors in our community ran scared and scared their patients and said “ I won’t practice this way and I don’t think you should go to her to obtain HRT.” This week, eighteen years after the controversy over the WHI study which was fatally flawed a study has been released that tracked over 27000 women who had received HRT for between five and seven years or more. This is considered long term treatment. The result is exciting: there is no supporting data that shows any increase in risk of death from all cause mortality among these women based on whether or not they have received hormone replacement therapy. There is no data that says HRT will increase your risk of death from any cause of death, particularly heart disease and cancers of all types. They are not saying it will keep you alive, but they are saying it won’t kill you. Now that we do not have to look at the risk of death with anxiety and fear, we can look at research that will talk about the quality of life and the health and improved quality of life that can happen when people obtain hormone replacement therapies when they need them. Not only can you safely consider the replacement of estrogen, you should also look at other hormones that our bodies make and use which decline as we age. Talk to your doctor about whether or not they are aware of this exciting new article in the most recent issue of JAMA and whether or not they are willing to recommend and provide HRT treatments for aging people.
Dr Alain Monnier - No link between aromatase inhibitors and cardiovascular problems
Dr Alain Monnier - Medical oncologist and head of the medical oncology department at the Centre Hospitalier de Belfort-Montbéliard - Speaking at the 6th European Breast Cancer Conference April 2008 - No link between aromatase inhibitors and cardiovascular problems
Views: 359 ecancer
Dr Pam Popper: Breast Biopsies Often Inaccurate; Exercise as Treatment for Breast Cancer
Breast biopsies are supposed to provide definite diagnoses, but it looks like their accuracy has been over-exaggerated. And a new study shows that exercise can increase the efficacy of chemotherapy in treating cancer, and may even be as effective as chemotherapy.
Views: 1579 Pamela Popper
Risk for heart problems in breast cancer patients
There is a risk of a heart condition among breast cancer patients. Certain drug therapies, along with radiation, can increase the risk of damaging the heart muscle.
Views: 69 WTNH News8
Radical Remission from Cancer with Kelly Turner
Kelly Turner, Ph.D., is a researcher, author, and lecturer in the field of integrative oncology. She received her B.A. from Harvard University, and did her Ph.D. at the University of California, Berkeley, where her dissertation focused on the Radical Remission of cancer, which is a remission that occurs either in the absence of Western medicine, or after Western medicine has failed to achieve remission. The Radical Remission Project, which she founded, is an innovative website dedicated both to collecting new cases of Radical Remission for research purposes, and to connecting Radical Remission survivors with current cancer patients. Her new book, RADICAL REMISSION: The Nine Key Factors That Can Make a Real Difference, encapsulates the fascinating findings of her research. Kelly's website is www.radicalremission.com/
Views: 4999 Miriam Knight
Britain offers preventive drug for breast cancer
Preventive drugs for breast cancer will be offered to healthy women in Britain. It is the first... euronews, the most watched news channel in Europe Subscribe for your daily dose of international news, curated and explained:http://eurone.ws/10ZCK4a Euronews is available in 13 other languages: http://eurone.ws/17moBCU http://www.euronews.com/2013/06/25/britain-offers-preventive-drug-for-breast-cancer Preventive drugs for breast cancer will be offered to healthy women in Britain. It is the first time it has happened in Europe. Thousands of women who are 35 or over with a family history of the disease will be offered drugs available on the country's National Health Service. The National Institute for Health and Care Excellence believes the move could reduce the chances of catching the disease by 40 percent. The women will be offered a daily five-year course of Tamoxifen or Raloxifene. Experts say women will have to weigh up their options carefully. Tamoxifen has known side-effects. Hollywood actress Angelina Jolie revealed recently she had undergone a double mastectomy. She carries a known risky gene which can increase the chance of catching the disease. Find us on: Youtube http://bit.ly/zr3upY Facebook http://www.facebook.com/euronews.fans Twitter http://twitter.com/euronews
Dr Pam Popper: Soy & Breast Cancer; We're Getting Sicker, Not Better
It seems that the discussion of isoflavones, soy foods and breast cancer never ends, so here's another study documenting my point that soy foods are safe. And don't believe what we're being told about Americans enjoying better health -- we aren't, and this data shows how much worse we really are.
Views: 5051 Pamela Popper
Dr. Oz: 3 Ways to Help Prevent Osteoporosis | The Oprah Winfrey Show | Oprah Winfrey Network
Feeling aches and pains in your bones is an inevitable part of aging. However, according to Dr. Oz, there are three simple actions you can take today to help avoid developing unpleasant conditions like osteoporosis. Watch as America's favorite physician reveals the three steps to healthy bones and shows what a real-life osteoporotic spine looks like. For more on #oprahwinfreyshow, visit http://bit.ly/1ODj0x7 Find OWN on TV at http://www.oprah.com/FindOWN #OWNTV #oprahwinfreyshow #Oprahwinfrey SUBSCRIBE: http://bit.ly/1vqD1PN Download the Watch OWN App: http://bit.ly/2hr1nX2 Download the OWN Bold Moves App: http://bit.ly/2hglOIa About OWN: Oprah Winfrey Network is the first and only network named for, and inspired by, a single iconic leader. Oprah Winfrey's heart and creative instincts inform the brand -- and the magnetism of the channel. Winfrey provides leadership in programming and attracts superstar talent to join her in primetime, building a global community of like-minded viewers and leading that community to connect on social media and beyond. OWN is a singular destination on cable. Depth with edge. Heart. Star power. Connection. And endless possibilities. Discover OWN TV: Find OWN on your TV!: http://bit.ly/1wJ0ugI Our Fantastic Lineup: http://bit.ly/1qMi2jE Connect with OWN Online: Visit the OWN WEBSITE: http://bit.ly/1qMi2jE Like OWN on FACEBOOK: http://on.fb.me/1AXYujp Follow OWN on TWITTER: http://bit.ly/1sJin8Y Follow OWN on INSTAGRAM: http://bit.ly/LnqzMz Follow OWN on PINTEREST: http://bit.ly/2dvfPeN Dr. Oz: 3 Ways to Help Prevent Osteoporosis | The Oprah Winfrey Show | Oprah Winfrey Network http://www.youtube.com/user/OWN
Views: 147929 OWN
Treatments For Breast Cancer - Manipal Hospital
This animated video is an informative elaboration on treatment of breast cancer. The treatment options for breast cancer include surgery, radiation therapy, chemotherapy, and hormone therapy. There are several surgical options depending on the severity of the cancer. A lumpectomy removes the tumour and a small amount of neighbouring tissues. Mastectomy involves removing the entire breasts and its tissues. Sentinel lymph node removal is typically performed in addition to lumpectomies and mastectomies. Here your surgeon will remove the lymph nodes closest to the tumour and check it for the presence of the cancer cells. If this node is clean, it may not be necessary to remove more lymph nodes. A prophylactic mastectomy, is a preventive surgery for high-risk woman that removes the entire breast to lower the risk of breast cancer. Radiation therapy uses high-energy X-rays or other types of radiations to kill the cancer cells or to keep them from growing. Internal radiation therapy can be used to treat the cancer from the inside of your body using needles, wires or catheters. Watch the video to know more on the treatment of breast cancer. We are invested in the health and well-being of our community and frequently post informational videos on our channel in order to create awareness. Subscribe to our channel at http://bit.ly/2bkdHn8. To know more visit our website : https://www.manipalhospitals.com/ Get Connected Here: ================== Facebook: https://www.facebook.com/ManipalHospitalsIndia Google+: https://plus.google.com/111550660990613118698 Twitter: https://twitter.com/ManipalHealth Pinterest: https://in.pinterest.com/manipalhospital Linkedin: https://www.linkedin.com/company/manipal-hospital Instagram: https://www.instagram.com/manipalhospitals/ Foursquare: https://foursquare.com/manipalhealth Alexa: http://www.alexa.com/siteinfo/manipalhospitals.com Blog: https://www.manipalhospitals.com/blog/
Views: 4050 Manipal Hospitals
Chemotherapeutic agents
This is a brief overview of chemotherapeutic agents, their mechanism of action, and some related side effects. I created this presentation with Google Slides. Image were created or taken from Wikimedia Commons I created this video with the YouTube Video Editor. ADDITIONAL TAGS: Chemotherapeutic agents Classes of chemical agents used in the treatment of cancer Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Alkylating agents Attach alkyl groups to DNA, allows cross linking of base pairs, damaging DNA; cell cycle nonspecific Typical alkylating agents: cyclophosphamide, ifosfamide, melphalan, busulfan, mechlorethamine, chlorambucil, thiotepa Side effects: myelosuppression drop in WBC, Hb, crit, nausea/vomiting, secondary malignancies, infertility/impaired fertility, hemorrhagic cystitis hematuria, dysuria from direct irritation of bladder by acrolein metabolite Atypical alkylating agents Platinum compounds covalently bind purine DNA bases. Drugs and side effects: cisplatin causes nephrotoxicity and n/v carboplatin causes thrombocytopenia oxaliplatin causes cold sensitivity all cause peripheral neuropathies, paresthesia Nitrosoureas: BCNu, CCNu both cause pulmonary toxicity, phlebitis. CNS Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Antimetabolites Inhibit DNA replication or repair by mimicking normal cell compounds; S phase specific Folate inhibitor: Methotrexate inhibits DHFR, prevents regeneration of THF Adjuvant leucovorin to protect healthy cells adjuvant Side effect is mucositis, myelosuppression Pyrimidine inhibitors 5-fluorouracil inhibits thymidylate synthetase Bolus dose causes myelosuppression Continuous dose causes GI problems mucositis, diarrhea Synergistic leucovorin potentate mechanism of action synergistic Capecitabine is essentially an oral prodrug for 5-FU Side effect: hand-foot syndrome - palms and hands and feet become red, can start blistering Cytarabine AraC is a DNA chain terminator Side effects: conjunctivitis and cerebellar neural defects The 7 in 7+3 chemotherapy Purine analog is 6-mercaptopurine Alkylating agents Antimetabolites Microtubule targeting agents Topoisomerase inhibitors Anthracyclines Monoclonal antibodies Other agents Microtubule targeting agents These drugs inhibit mitosis, specifically M phase Vinca alkaloids destroy microtubules, obviously preventing their function Vincristine, vinblastine, and vinorelbine Side effects: peripheral neuropathy, myelosuppressive blast others Fatal if given intrathecally Taxanes stabilize microtubules, preventing their function Paclitaxol, docetaxol Side effects: myelosuppression, peripheral neuropathies Hypersensitivity from diluent: Cremophor diluent in paclitaxel Tween80 in docetaxel Avoid hypersenitivity with abraxane, protein-bound paclitaxol particles less sensitivity but more neuropathy Topoisomerase inhibitors Topoisomerase I inhibitors prevent relaxation of supercoiled DNA Topotecan, irinotecan Both have side effect of myelosuppression Irinotecan causes diarrhea: “I ran to the can” Topoisomerase II inhibitors prevent recoiling of DNA after transcription Etoposide, teniposide Both have side effects of myelosuppression, mucositis, secondary malignancies AML Etoposide also causes hypotension Anthracyclines Various mechanisms of action: intercalate DNA, inhibit topo II, generate ROS, perhaps alkylation -rubicins: doxorubicin, daunorubicin, idarubicin, epirubicin Side effects: biventricular heart failure, necrotic with extravasation The 3 in 7+3 chemotherapy Monoclonal antibodies Origin determined from suffixes: -omab from mouse; -ximab is chimeric cross between human/mouse; -umab is humanized; -mumab is fully human mAb Target Treats: Toxicity Rituximab CD20 lymphoma - Trastuzumab Her-2 breast cancer - Cetuximab EGFR solid tumors initially for colorectal cancer Acneiform rash Bevacizumab VEGF solid tumors initially for colorectal/lung cancers GI perforation, Other chemotherapeutic agents Bleomycin causes lung toxicity Side effects: pulmonary fibrosis, interstitial pneumonitis, hypersensitivity pneumonitis cough, infiltrates Hormonal therapies Antiestrogens block estrogen stimulation of breast cancer Tamoxifen, fulvestrant, megestrol acetate Aromatase inhibitors block synthesis of estrogen Anastrozole, letrozole Antiandrogens block androgen stimulation of prostate cancer Other targets for prostate cancer are LHRH agonists prevent testosterone production, GnRH antagonist, CYP17 inhibitor
Views: 112907 MedLecturesMadeEasy
Aromatase inhibitors cause a grave estrogen deficiency disease and should be avoided
Aromatase inhibitors cause a grave estrogen deficiency disease and ought to be avoided Aromatase inhibitors are adjuvants which cause a grave endocrine deficiency disease. They neither cure cancer nor prolong survival. If so why are the prescribed? Since the treatment objective of oncology is false. Oncology recommends these drugs since they improve Disease Free Survival (DFS). Yet the price is a medically caused disease. Breast irradiation is also an adjuvant. Yet while irradiation is dangerous to your health, clinical trials do not measure it. At best they talk about toxicities, which are actually medically induced (iatrogenic) diseases. Estrogen promotes tumor growth, and anti-estrogen retards it. There are two kinds of anti-promoters: 1. Tamoxifen: Estrogen receptor antagonist. 2. Exemestane (Aromasin): Aromatase inhibitor. While tamoxifen antagonizes local estrogen receptors, aromasin treatment causes an estrogen deficiency disease which affects many functions of the organism, and is manifested by bad side effects. Aromatase inhibitors should therefore be forbidden. You may treat a woman with estrogen receptors with tamoxifen, yet when it fails do not switch to aromasin.Continue with chemotherapy. Generally when a tumor recurs even tamoxifen is of no avail. It should not be prescribed to a patient with recurrent disease.
Views: 3778 Gershom Zajicek M.D,
TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen...
San Antonio Breast Cancer Symposium 2010 - A discussion with Dr. Thomas Bachelot, France, on TAMRAD: A GINECO Randomized Phase II Trial of Everolimus in Combination with Tamoxifen Versus Tamoxifen Alone in Patients (pts) with Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer (MBC) with Prior Exposure to Aromatase Inhibitors (AI).
Views: 858 Oncology.TV
Why is Kyani NitroFX so Powerful?   Dr. Craig Bubler
http://bedrock.kyaniviral.com Published on Aug 10, 2013 Dr Barrie Tan Ph.D. Little-known anti-cancer research with promising possibilities In terms of cancer prevention and treatment, tocotrienols seem to be able to neutralize something called vascular endothelial growth factor (VEGF). This is important when you're battling cancer, since VEGF prompts the development of new blood vessels built to feed growing tumors. This process whereby cancer forms its own network of blood vessels is called angiogenesis. If tocotrienols indeed slow down or stop BOTH angiogenesis and apoptosis, it's a very big deal. At the very least, we've seen this promising research come out about the specific benefits of tocotrienols: •Pancreatic cancer: Tocotrienols appear to be the more effective antioxidant over tocopherols thanks to their unsaturated side chain. That chain allows the compound to penetrate better into saturated, fatty layers of the liver and brain, which gives it an advantage in terms of halting the formation of tumors, DNA damage, and cell damage. A 1993 study on rats with liver cancer proved this.2 Less liver cell damage was detected in the group that received palm tocotrienols. •Breast cancer: In vitro studies conducted in the 1990s showed tocotrienols helped inhibit the growth of human breast cancer cells. Tocotrienols appeared to work synergistically with tamoxifen, (a common breast cancer medicine) to kill cancer cells.3 Delta-tocotrienols appeared be the most effective in inducing apoptosis in cancer cells, and gamma-tocotrienols supposedly inhibit ld1, a key cancer-promoting protein. •Prostate cancer: Different studies show delta- and gamma-tocotrienols suppress prostate cancer cell proliferation. In contrast, another study showed that alpha-tocopherol enhanced cancer cell growth.4 •Skin cancer: In a study at the University of Hong Kong, skin cancer cell numbers decreased when treated with gamma-tocotrienol and chemotherapy drugs.5 Other studies have shown tocotrienols suppress the growth of melanoma.6 These studies seem promising because they're focused specifically on tocotrienols. But as a whole the research is confusing. For example, some studies show lower prostate and breast cancer rates are associated with a higher intake of vitamin E. Yet, postmenopausal breast cancer incidence appears unaffected by vitamin E intake. Part of the problem is that the scientific community only recently started to pay attention to tocotrienols. Most research up until a few years ago focused on alpha-tocopherol. Studies on tocotrienols made up less than 1% of total research on vitamin E. That's starting to change. Now researchers have ramped up their efforts to understand tocotrienols. In the past few years, almost 30% of the peer-reviewed studies on vitamin E have been specific to tocotrienols. Based on those few studies, tocotrienols so far have been shown to be safe. They appear to have no adverse effects when taken for a period as long as four years (the length of the longest study to date). How to get hold of this natural, cancer-altering treatment If you're looking for the most powerful anti-cancer properties from vitamin E, go for the tocotrienols. You can purchase yours here : http://bedrock.kyaniviral.com For information on how you can become a distributor go here: http://bedrock.stoptherock.com Posted by: Bruce Avellanet, The Dallas Note Buyer
Views: 2816 Bruce Avellanet
A Cancer Surgeon Says Less Is Better
A prominent breast cancer surgeon thinks less testing and treatment for many types of cancer would be better. When a surgeon says it is time to do less surgery, it’s time to listen!
Views: 3971 Pamela Popper
Opeyemi, a feral M.D. shares from the heart on tips for preventing breast cancer. IMPORTANT LINKS: http://www.bcaction.org/2013/06/10/ductal-carcinoma-in-situ-dcis-the-facts-around-the-controversy/ my site: www.ceremonyheals.com Movie review: http://www.npr.org/2012/05/31/153912165/pink-ribbons-tied-up-with-more-than-hope and breast cancer action site: www.bca.org
Views: 203 Opeyemi Parham
Using Risk Models for Breast Cancer Prevention
Using Risk Models for Breast Cancer Prevention Air date: Wednesday, February 27, 2013, 3:00:00 PM Description: Wednesday Afternoon Lecture Series Dr. Gail uses statistical methods for the design and analysis of epidemiologic studies including studies of genetic factors and models to predict the absolute risk of disease. Epidemiologic studies have established several risk factors for breast cancer such as family history, age when giving birth for the first time, biopsy findings, and mammographic density. These factors can be combined with breast cancer incidence rates to construct models of absolute risk of breast cancer. Absolute risk is the risk of developing a disease over a defined age interval or time period; relative risk is used to compare risks in different groups of people. Absolute risk is useful for counseling women and in public-health applications. In counseling, absolute risk estimates provide realistic perspectives and inform decision-making such as when or whether to begin having screening mammographies. Absolute risk estimates are also useful in weighing the risks and benefits, for example, of chemopreventive therapies such as tamoxifen or raloxifene. Public health applications of risk models include designing chemoprevention trials; implementing "high risk" prevention strategies that focus only on women who are at highest risk for breast cancer; assessing the potential of preventive interventions to reduce absolute breast cancer risk in the population; and using risk estimates to allocate prevention resources under cost constraints. Dr. Gail will review the usefulness of risk models in these applications and the potential of additional risk factors, such as single nucleotide polymorphisms, to improve the performance of those models. Author: Mitchell H. Gail, M.D., Ph.D., National Cancer Institute Runtime: 01:03:57 Permanent link: http://videocast.nih.gov/launch.asp?17823
Views: 1525 nihvcast
"Do breast cancer prevention methods differ for pre- vs. post-menopausal women?"
"Do breast cancer prevention methods differ for pre- vs. post-menopausal women?" Response by: Laura Esserman Pamela Goodwin -- from the audience Patricia Ganz -- from the audience ("Who would tamoxifen be recommended for?"
Pharmacogenomics - Howard McLeod (2016)
May 4, 2016 - Current Topics in Genome Analysis 2016 More: http://www.genome.gov/CTGA2016
Reduce Cancer Risk: 7 Changes to Make to Your Routine
Find out more about Breast Cancer Index (BCI): http://www.breastcanceranswers.com/breastcancerindex/ There are countless articles warning you things that might increase your risk of cancer. It's impossible to stay from all of them. So we put together 7 simple changes you can make to your daily routine to reduce your risk of breast cancer or prevent recurrence. SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS http://www.youtube.com/user/drjayharness VISIT BREASTCANCERANSWERS.com FOR THE LATEST IN BREAKING BREAST CANCER NEWS http://www.breastcanceranswers.com/news SUBMIT A QUESTION http://www.breastcanceranswers.com/ DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR http://www.breastcanceranswers.com/ CONNECT WITH US! Google+: http://bit.ly/16nhEnr Facebook: https://www.facebook.com/BreastCancerAnswers Twitter: https://twitter.com/BreastCancerDr
Dr Pam Popper: Pre-Diabetes & Cancer Treatment for Mild Hypertension
One thing leads to another – people with even slightly elevated levels of fasting glucose are at higher risk of developing cancer. Dietary intervention at the first sign of health decline should be the rule. And, more doctors are starting to acknowledge that people with mild hypertension should not be medicated – we are hurting more people than we help with this strategy, and one outspoken doctors has publicly said that the money we spend on drugs should be diverted to helping people change their diets.
Views: 1327 Pamela Popper
Breast Cancer Nutrition, Cancer Coach's Tips - Elyn Jacobs
Elyn Jacobs is a breast cancer survivor and certified cancer coach. During her cancer treatment she discovered how what she was putting into her body, helped or hindered her body in it's fight against cancer. She gives three very easy to follow and helpful tips on how you can help your body fight cancer by altering your diet. See other tips form Elyn at http://www.breastcancerasnswers.com/category/breast-cancer-wisdom Elyn can also be found at http://www.elynjacobs.wordpress.com Click Here & Get The 15 Breast Cancer Questions To Ask Your Doctor http://www.breastcanceranswers.com/what-breast-cancer-questions-to-ask/# Breast Cancer Answers is a social media show where viewers submit a question and get the answer from an expert. Submit your question now at, http://www.breastcanceranswers.com/ask. This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
Breast Cancer Prevention Surgeries Under Scrutiny
http://www.dailyrxnews.com/mastectomy-lumpectomy-made-no-difference-death-rates-ductal-carcinoma-situ-patients Thousands of women undergo surgeries every year after an early breast cancer diagnosis. But could these treatments be unnecessary? A new study from Canada found no difference in death outcomes between women who underwent a lumpectomy (tumor removal) or a mastectomy (breast removal) after an early breast cancer diagnosis and women who did not undergo treatment.
Views: 78 dailyRx
Karuna Jaggar speaks about Aromasin on KPIX
Breast Cancer Action (BCAction) called for caution about the implications of a recently published study exploring the use of the drug Aromasin (exemestane), an aromatase inhibitor (AI), in healthy postmenopausal women to reduce the risk of invasive breast cancer. The study, led by Canada's NCIC Clinical Trials Group, presented at the American Society of Clinical Oncology's conference on June 4, 2011 and financed in part by the pharmaceutical giant Pfizer, examined the use of an aromatase inhibitor for reducing women's risk of breast cancer. The study showed that women taking Aromasin developed breast cancer at a lower rate than those taking the placebo. BCAction expressed concern about the tendency to expand approved breast cancer treatment drugs into broader markets, including prevention, without the necessary rigor to determine which women would actually benefit from the drug. In this study, women were considered at high risk of developing breast cancer if they had identified risk factors or were at least 60 years old. "When exploring 'preventive' treatment for breast cancer in healthy women, the bar needs to be especially high," BCAction Executive Director Karuna R. Jaggar said. "Without a rigorous definition of "high risk", this study opens the door to exposing thousands and thousands of healthy women who will never get breast cancer to the side effects of a powerful drug." Specifically, BCAction expressed concern about this study's broad categorization of women as high risk for breast cancer based solely on being age 60 years or older, noting that this could open the door to treating all women over 60 with an aromatase inhibitor. BCAction reiterated its opposition to "pills for prevention," due partly to a lack of information about the long-term effects on healthy women taking drugs like Aromasin. Study sizes are too small, and follow-up too short, to reveal rarely occurring adverse outcomes or to assess the possibility that risks continue to develop after cessation of treatment. "While every person diagnosed with breast cancer is one too many, this study shows you would have to treat 94 healthy women for several years with a powerful drug in order to prevent one case of breast cancer," Jaggar said. "In addition, we don't know what the long term effects of taking this drug will be on these healthy women." BCAction remains committed to primary prevention of breast cancer, which necessitates directing resources and funding to determining and eliminating the root causes of breast cancer, including environmental triggers. "This drug is a huge moneymaker for any company and we believe it is the wrong path to take," Jaggar said. "We believe these resources should be better spent on primary prevention including finding the disease's environmental triggers." Breast Cancer Action (www.bcaction.org) is a national watchdog and advocacy organization that carries the voices of people affected by breast cancer to inspire and compel the changes necessary to end the breast cancer epidemic.
My metastatic breast cancer treatment at MD Anderson in Sugar Land
After undergoing breast cancer treatment consisting of 36 rounds of radiation and Taxol, as well as Tamoxifen, Myriam Saenz is now facing breast cancer metastasis. But with the support of her care team at MD Anderson in Sugar Land, she is confident that she will again beat breast cancer. Watch this inspiring metastatic breast cancer survivor share her story. Learn more about breast cancer treatment at MD Anderson: http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/breast-cancer/treatment/index.html Request an appointment at MD Anderson by calling 1-877-632-6789 or online at: https://my.mdanderson.org/RequestAppointment?cmpid=youtube_appointment_breast